February 3, 2015

Dr. Gordon L. Amidon received a Doctor Honoris Causa (Honorary Doctorate) from the Miguel Hernández (UMH) University of Elche in Alicante, Spain on January 28, 2015. The investiture ceremony took place during the celebration of the feast of St. Thomas Aquinas.

This degree is conferred in recognition of notable contributions of an individual to his or her field of expertise, and the recognition of peers of extraordinary accomplishments.  Dr. Amidon was nominated for this award by Dr. Marival Bermejo Sanz, a long-time colleague and collaborator.

Dr. Amidon is best known for his establishment of the Biopharmaceutics Classification System (BCS), which is currently in use by the U.S. Food and Drug Administration for classification and regulation of pharmaceuticals, in addition to being a guideline that is used internationally.

"This honorary degree from UMH, a foreign institution, most notably a Spanish Institution, is particularly significant to me because it signifies accomplishment in two very different ways; one is the significant recognition of my pharmaceutical scientific contributions on an international scale, the second is more specific to my ambition to extend the impact of my vision of biopharmaceutical science and pharmaceutical product regulatory science to the Spanish speaking world, especially South America," explains Dr. Amidon.

Congratulations to Dr. Amidon on this wonderful accomplishment!

Learn more: